These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1169 related articles for article (PubMed ID: 35025730)

  • 1. Breaking antimicrobial resistance by disrupting extracytoplasmic protein folding.
    Furniss RCD; Kaderabkova N; Barker D; Bernal P; Maslova E; Antwi AAA; McNeil HE; Pugh HL; Dortet L; Blair JMA; Larrouy-Maumus G; McCarthy RR; Gonzalez D; Mavridou DAI
    Elife; 2022 Jan; 11():. PubMed ID: 35025730
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a sensor for disulfide bond formation in diverse bacteria.
    Dyotima ; Abulaila S; Mendoza J; Landeta C
    J Bacteriol; 2024 Apr; 206(4):e0043323. PubMed ID: 38493438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Combining Colistin with Furanone C-30 Rescues Colistin Resistance of Gram-Negative Bacteria
    Zhang Y; Lin Y; Zhang X; Chen L; Xu C; Liu S; Cao J; Zheng X; Jia H; Chen L; Zhou T
    Microbiol Spectr; 2021 Dec; 9(3):e0123121. PubMed ID: 34730415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Colistin kills bacteria by targeting lipopolysaccharide in the cytoplasmic membrane.
    Sabnis A; Hagart KL; Klöckner A; Becce M; Evans LE; Furniss RCD; Mavridou DA; Murphy R; Stevens MM; Davies JC; Larrouy-Maumus GJ; Clarke TB; Edwards AM
    Elife; 2021 Apr; 10():. PubMed ID: 33821795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Design SMAP29-LysPA26 as a Highly Efficient Artilysin against Pseudomonas aeruginosa with Bactericidal and Antibiofilm Activity.
    Wang T; Zheng Y; Dai J; Zhou J; Yu R; Zhang C
    Microbiol Spectr; 2021 Dec; 9(3):e0054621. PubMed ID: 34878337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of β-Ketoacyl Acyl Carrier Protein Synthase III Activity Restores Multidrug-Resistant Escherichia coli Sensitivity to Previously Ineffective Antibiotics.
    Hong Y; Qin J; Verderosa AD; Hawas S; Zhang B; Blaskovich MAT; Cronan JE; Totsika M
    mSphere; 2022 Jun; 7(3):e0011722. PubMed ID: 35574679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. On the Offensive: the Role of Outer Membrane Vesicles in the Successful Dissemination of New Delhi Metallo-β-lactamase (NDM-1).
    Martínez MMB; Bonomo RA; Vila AJ; Maffía PC; González LJ
    mBio; 2021 Oct; 12(5):e0183621. PubMed ID: 34579567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Galleria mellonella infection model reveals double and triple antibiotic combination therapies with enhanced efficacy versus a multidrug-resistant strain of Pseudomonas aeruginosa.
    Krezdorn J; Adams S; Coote PJ
    J Med Microbiol; 2014 Jul; 63(Pt 7):945-955. PubMed ID: 24928215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A Whole-Cell Screen Identifies Small Bioactives That Synergize with Polymyxin and Exhibit Antimicrobial Activities against Multidrug-Resistant Bacteria.
    Zimmerman SM; Lafontaine AJ; Herrera CM; Mclean AB; Trent MS
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31844003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Demonstration of the efficacy of curcumin on carbapenem-resistant Pseudomonas aeruginosa with Galleria mellonella larvae model.
    Ozturk S
    Arch Microbiol; 2022 Jul; 204(8):524. PubMed ID: 35882691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bicyclomycin Activity against Multidrug-Resistant Gram-Negative Pathogens.
    Wang W; Zhu X; Luo H; Wang Z; Hong A; Zeng J; Li L; Wang D; Deng X; Zhao X
    Microbiol Spectr; 2023 Feb; 11(1):e0379022. PubMed ID: 36533939
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Species-specific activity of antibacterial drug combinations.
    Brochado AR; Telzerow A; Bobonis J; Banzhaf M; Mateus A; Selkrig J; Huth E; Bassler S; Zamarreño Beas J; Zietek M; Ng N; Foerster S; Ezraty B; Py B; Barras F; Savitski MM; Bork P; Göttig S; Typas A
    Nature; 2018 Jul; 559(7713):259-263. PubMed ID: 29973719
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Mla Pathway Plays an Essential Role in the Intrinsic Resistance of Burkholderia cepacia Complex Species to Antimicrobials and Host Innate Components.
    Bernier SP; Son S; Surette MG
    J Bacteriol; 2018 Sep; 200(18):. PubMed ID: 29986943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fast bacterial growth reduces antibiotic accumulation and efficacy.
    Łapińska U; Voliotis M; Lee KK; Campey A; Stone MRL; Tuck B; Phetsang W; Zhang B; Tsaneva-Atanasova K; Blaskovich MAT; Pagliara S
    Elife; 2022 Jun; 11():. PubMed ID: 35670099
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of Action of Isopropoxy Benzene Guanidine against Multidrug-Resistant Pathogens.
    Li J; Zhang X; Han N; Wan P; Zhao F; Xu T; Peng X; Xiong W; Zeng Z
    Microbiol Spectr; 2023 Feb; 11(1):e0346922. PubMed ID: 36475769
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Amphiphilic nebramine-based hybrids Rescue legacy antibiotics from intrinsic resistance in multidrug-resistant Gram-negative bacilli.
    Yang X; Ammeter D; Idowu T; Domalaon R; Brizuela M; Okunnu O; Bi L; Guerrero YA; Zhanel GG; Kumar A; Schweizer F
    Eur J Med Chem; 2019 Aug; 175():187-200. PubMed ID: 31078866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using Small-Molecule Adjuvants to Repurpose Azithromycin for Use against Pseudomonas aeruginosa.
    Hubble VB; Hubbard BA; Minrovic BM; Melander RJ; Melander C
    ACS Infect Dis; 2019 Jan; 5(1):141-151. PubMed ID: 30444345
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility profiles of gram-negative bacteria causing infections collected across India during 2014-2016: Study for monitoring antimicrobial resistance trend report.
    Veeraraghavan B; Jesudason MR; Prakasah JAJ; Anandan S; Sahni RD; Pragasam AK; Bakthavatchalam YD; Selvakumar RJ; Dhole TN; Rodrigues C; Roy I; Joshi S; Chaudhuri BN; Chitnis DS
    Indian J Med Microbiol; 2018; 36(1):32-36. PubMed ID: 29735823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of a novel class of boron-based antibacterials with activity against gram-negative bacteria.
    Hernandez V; Crépin T; Palencia A; Cusack S; Akama T; Baker SJ; Bu W; Feng L; Freund YR; Liu L; Meewan M; Mohan M; Mao W; Rock FL; Sexton H; Sheoran A; Zhang Y; Zhang YK; Zhou Y; Nieman JA; Anugula MR; Keramane el M; Savariraj K; Reddy DS; Sharma R; Subedi R; Singh R; O'Leary A; Simon NL; De Marsh PL; Mushtaq S; Warner M; Livermore DM; Alley MR; Plattner JJ
    Antimicrob Agents Chemother; 2013 Mar; 57(3):1394-403. PubMed ID: 23295920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Restoring and Enhancing the Potency of Existing Antibiotics against Drug-Resistant Gram-Negative Bacteria through the Development of Potent Small-Molecule Adjuvants.
    Yu B; Roy Choudhury M; Yang X; Benoit SL; Womack E; Van Mouwerik Lyles K; Acharya A; Kumar A; Yang C; Pavlova A; Zhu M; Yuan Z; Gumbart JC; Boykin DW; Maier RJ; Eichenbaum Z; Wang B
    ACS Infect Dis; 2022 Aug; 8(8):1491-1508. PubMed ID: 35801980
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 59.